BeGOOD is a research study, comprised of distinct but overlapping studies, focusing on the ethical, societal and scientific dimensions of the early intervention paradigm where it intersects with psychiatry, mental health and child development.

One of our earlier research studies, Psychosis Early Intervention Ethics (EIE) investigated the conceptualization and enactment of ‘good practice’ in early intervention in psychosis services from the perspectives of service users and clinicians. Mothers EIE investigated the social, political and ethical dimensions of early intervention in maternal and child development drawing on fieldwork among families enrolled in a community-led early intervention programme in Northern Ireland and Mother and Baby Units in UK Women’s Prisons.

Recent research has focused on investing young people’s values, preferences and experiences relating to genetics related to Alzheimer’s Disease, Autism and lastly young people’s everyday moral attitudes and experiences.

A core component of our research focuses on involving young people in the development of our research, through our Young People’s Advisory Groups (YPAG) who meet regularly. Around 30 young people aged between 16 and 18 years from Oxfordshire take part in our groups: together they form one group focusing on mental health and the second on ethics. We belong to GenerationR, a national YPAG alliance and work with researchers across the University of Oxford to involve YPAG members in broader mental health and clinical research.

BeGOOD is based in the Neuroscience, Ethics and Society research group (known as NEUROSEC) at the University of Oxford. NEUROSEC specialises in ethics of early intervention and prevention strategies becoming possible due to advances in neuroscience, genomics and big data projects. We conduct independent ethics research and we deliver ethical guidance for a range of scientific and clinical studies in the Oxford Department of Psychiatry and Neuroscience.  Our core research interests involve young people, mental health and neuroscience innovations in a global context.